ATH 0.00% 0.5¢ alterity therapeutics limited

Ann: Alterity Granted New Composition of Matter Patent in Europe, page-15

  1. 2,031 Posts.
    lightbulb Created with Sketch. 524
    perhaps it’s the unknown question of how much will need to be raised and at what price? I’m not touching this again until that those questions are answered, likely post consolidation. At these prices, a big raise will dilute holders to smithereens. And then what are the future catalysts to sp appreciation other than pivaldes unrelenting belief in “the fund” having some involvement with pbt2?

    wish holders the best obviously and they will get it if a reward is paid given the risk/reward on this is extreme. Whether it’s a good proposition though depends on the price you bought at though and it could get better yet.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $5.1K 1.02M

Buyers (Bids)

No. Vol. Price($)
48 69461182 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 21658481 10
View Market Depth
Last trade - 16.10pm 31/05/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.000 ( 10.0 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 1258823
Last updated 15.59pm 31/05/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.